๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
iX Biopharma Ltd. (SGX:42C)
Singapore flag Singapore ยท Delayed Price ยท Currency is SGD
0.4550
0.00 (0.00%)
At close: Nov 18, 2026

iX Biopharma Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
7.966.857.775.965.9114.39
Revenue Growth
6.17%-11.77%30.34%0.78%-58.91%724.64%
Gross Profit
3.72.432.041.052.3212.29
Operating Income
-11.46-9.56-6.29-7.5-9.540.5
Net Income
-10.76-7.99-10.14-10.79-9.62-4.6
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '25 Jun '24 Jun '23 Jun '22
Specialty Pharmaceuticals
5.637.075.655.3513.92
Nutraceutical
1.691.110.510.750.62
Inter-Segment Sales
-0.47-0.42-0.2-0.19-0.15
Total
6.857.775.965.9114.39

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
11.3614.930.941.846.5313.59
Total Debt
3.445.85.95.24.344.41
Net Cash (Debt)
7.929.13-4.97-3.362.29.18
Net Cash Growth
-----76.08%363.97%
Net Cash Per Share
0.010.01-0.01-0.000.000.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-9.74-7.51-3.76-6.55-7.663.12
Capital Expenditures
-0.19-0.12-0.2-0.27-0.7-0.2
Free Cash Flow
-9.93-7.62-3.96-6.83-8.362.92
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
46.48%35.52%26.27%17.59%39.24%85.41%
Operating Margin
-143.89%-139.52%-80.92%-125.78%-161.41%3.48%
Pretax Margin
-135.00%-116.50%-130.55%-167.56%-164.15%-28.49%
Profit Margin
-135.10%-116.64%-130.56%-181.14%-162.61%-31.95%
FCF Margin
-124.73%-111.21%-50.97%-114.57%-141.30%20.31%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-21.3621.3621.3621.3621.36
P/FCF Ratio
-----41.89
PS Ratio
62.4956.891.833.7411.798.51